Literature DB >> 19475362

[Sociomedical implications of the inability to commute in patients with cold urticaria].

W Nürnberg1, J Grabbe, H-J Glawe, R Stoll.   

Abstract

One of the important functions of the dermatologist working within a social medicine framework is the determination of social security disability benefits. The primary decision deals with the question which type of work the applicant can be asked to do and to what extent. Depending on the results of the medical assessment, social security disability benefits may be approved given that other insurance criteria specific to the applicant have been met. The following case demonstrates for the first time that a significant idiopathic cold urticaria leads to a severe constraint on keeping employment due to the inability to commute. The scenario shows that the cold urticaria severely restricts social and professional interactions and that the reduced ability to commute to the place of employment must receive special consideration within the context of a sociomedical evaluation.

Entities:  

Mesh:

Year:  2010        PMID: 19475362     DOI: 10.1007/s00105-009-1775-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  10 in total

1.  [Physical urticaria].

Authors:  M Fleischer; J Grabbe
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

2.  [The international classification of functioning, disability and health (ICF) in dermatological rehabilitation: conception, application, perspective].

Authors:  H H Niederauer; G Schmid-Ott; N Buhles
Journal:  Hautarzt       Date:  2005-07       Impact factor: 0.751

Review 3.  EAACI/GA2LEN/EDF guideline: management of urticaria.

Authors:  T Zuberbier; C Bindslev-Jensen; W Canonica; C E H Grattan; M W Greaves; B M Henz; A Kapp; M M A Kozel; M Maurer; H F Merk; T Schäfer; D Simon; G A Vena; B Wedi
Journal:  Allergy       Date:  2006-03       Impact factor: 13.146

4.  [Modern diagnosis and treatment of urticaria: five case reports].

Authors:  D Wieczorek; U Raap; A Kapp; B Wedi
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751

5.  [Epidemiology and clinical aspects of cold urticaria].

Authors:  A Möller; M Henning; T Zuberbier; B M Czarnetzki-Henz
Journal:  Hautarzt       Date:  1996-07       Impact factor: 0.751

6.  Chronic urticaria: importance of a medical-psychological approach.

Authors:  A M Berrino; S Voltolini; D Fiaschi; S Pellegrini; D Bignardi; P Minale; C Troise; E Maura
Journal:  Eur Ann Allergy Clin Immunol       Date:  2006-05

7.  Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria.

Authors:  A A Wanderer; K E Grandel; S I Wasserman; R S Farr
Journal:  J Allergy Clin Immunol       Date:  1986-09       Impact factor: 10.793

8.  High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study.

Authors:  Frank Siebenhaar; Franziska Degener; Torsten Zuberbier; Peter Martus; Marcus Maurer
Journal:  J Allergy Clin Immunol       Date:  2009-02-06       Impact factor: 10.793

9.  Acquired cold urticaria symptoms can be safely prevented by ebastine.

Authors:  M Magerl; J Schmolke; F Siebenhaar; T Zuberbier; M Metz; M Maurer
Journal:  Allergy       Date:  2007-09-26       Impact factor: 13.146

10.  Cold urticaria. Clinical findings in 220 patients.

Authors:  H Neittaanmäki
Journal:  J Am Acad Dermatol       Date:  1985-10       Impact factor: 11.527

  10 in total
  1 in total

1.  [Cold-induced urticaria and angioedema. Classification, diagnosis and therapy].

Authors:  K Krause; F Degener; S Altrichter; E Ardelean; D Kalogeromitros; M Magerl; M Metz; F Siebenhaar; K Weller; M Maurer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.